Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 8.25935064 |
2 | negative thymic T cell selection (GO:0045060) | 7.98561537 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.74174576 |
4 | negative regulation of cell killing (GO:0031342) | 7.66863723 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.66863723 |
6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.29053258 |
7 | positive thymic T cell selection (GO:0045059) | 7.03268427 |
8 | positive T cell selection (GO:0043368) | 6.79542975 |
9 | thymic T cell selection (GO:0045061) | 6.70459996 |
10 | regulation of T cell tolerance induction (GO:0002664) | 6.50644179 |
11 | T cell selection (GO:0045058) | 6.41643010 |
12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.33463372 |
13 | tolerance induction (GO:0002507) | 6.28811839 |
14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.27695634 |
15 | response to interleukin-15 (GO:0070672) | 6.25887099 |
16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.09766778 |
17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.09766778 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.94553231 |
19 | cellular response to interleukin-15 (GO:0071350) | 5.86123805 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 5.84002004 |
21 | interferon-gamma production (GO:0032609) | 5.65183597 |
22 | hepatocyte apoptotic process (GO:0097284) | 5.51469766 |
23 | positive regulation of tolerance induction (GO:0002645) | 5.22742096 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16019735 |
25 | leukocyte aggregation (GO:0070486) | 5.11013811 |
26 | T cell costimulation (GO:0031295) | 5.09409800 |
27 | T cell receptor signaling pathway (GO:0050852) | 5.07698025 |
28 | lymphocyte costimulation (GO:0031294) | 5.05054402 |
29 | T cell migration (GO:0072678) | 5.03416374 |
30 | regulation of regulatory T cell differentiation (GO:0045589) | 4.91655129 |
31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.91239202 |
32 | membrane raft organization (GO:0031579) | 4.80573497 |
33 | negative regulation of T cell mediated immunity (GO:0002710) | 4.66340497 |
34 | hemidesmosome assembly (GO:0031581) | 4.64730768 |
35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.64416202 |
36 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62335604 |
37 | regulation of tolerance induction (GO:0002643) | 4.59688479 |
38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.55543111 |
39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55028959 |
40 | positive regulation of isotype switching (GO:0045830) | 4.36038785 |
41 | regulation of isotype switching (GO:0045191) | 4.28520454 |
42 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.27869959 |
43 | positive regulation of interleukin-2 production (GO:0032743) | 4.18930659 |
44 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.16887683 |
45 | melanin metabolic process (GO:0006582) | 4.13834655 |
46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.10104667 |
47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.08907747 |
48 | striated muscle atrophy (GO:0014891) | 4.05428759 |
49 | melanin biosynthetic process (GO:0042438) | 4.01694642 |
50 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.00293685 |
51 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.00293685 |
52 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.99014795 |
53 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.98571659 |
54 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.95383764 |
55 | positive regulation of B cell mediated immunity (GO:0002714) | 3.95383764 |
56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.92640657 |
57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.92640657 |
58 | activated T cell proliferation (GO:0050798) | 3.89491248 |
59 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.87779441 |
60 | regulation of B cell mediated immunity (GO:0002712) | 3.77119006 |
61 | positive regulation of DNA recombination (GO:0045911) | 3.73822305 |
62 | positive regulation of humoral immune response (GO:0002922) | 3.72831008 |
63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.71660224 |
64 | regulation of immunoglobulin production (GO:0002637) | 3.60732360 |
65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.51689792 |
66 | alpha-beta T cell differentiation (GO:0046632) | 3.49787155 |
67 | skeletal muscle adaptation (GO:0043501) | 3.49565121 |
68 | alpha-beta T cell activation (GO:0046631) | 3.48936489 |
69 | T cell differentiation (GO:0030217) | 3.44846049 |
70 | desmosome organization (GO:0002934) | 3.43842140 |
71 | mast cell activation (GO:0045576) | 3.41090106 |
72 | positive regulation of immunoglobulin production (GO:0002639) | 3.40889820 |
73 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.37492350 |
74 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.35248742 |
75 | muscle atrophy (GO:0014889) | 3.33260125 |
76 | regulation of response to interferon-gamma (GO:0060330) | 3.31793731 |
77 | regulation of interleukin-2 production (GO:0032663) | 3.29166470 |
78 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.29163896 |
79 | regulation of B cell differentiation (GO:0045577) | 3.25897795 |
80 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.25818871 |
81 | T cell homeostasis (GO:0043029) | 3.25385231 |
82 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.25074527 |
83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.21831757 |
84 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.17092323 |
85 | secondary metabolite biosynthetic process (GO:0044550) | 3.16612657 |
86 | muscle filament sliding (GO:0030049) | 3.14779385 |
87 | actin-myosin filament sliding (GO:0033275) | 3.14779385 |
88 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.14718437 |
89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.13348178 |
90 | leukocyte cell-cell adhesion (GO:0007159) | 3.11826034 |
91 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.11697600 |
92 | keratinocyte development (GO:0003334) | 3.11057049 |
93 | regulation of cell killing (GO:0031341) | 3.10502334 |
94 | regulation of defense response to virus by virus (GO:0050690) | 3.09803366 |
95 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.08181213 |
96 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.07606674 |
97 | T cell activation (GO:0042110) | 3.07192423 |
98 | melanocyte differentiation (GO:0030318) | 3.05841540 |
99 | T cell proliferation (GO:0042098) | 3.03533979 |
100 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01860333 |
101 | sarcomere organization (GO:0045214) | 3.00924906 |
102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99959816 |
103 | positive regulation of T cell activation (GO:0050870) | 2.99519595 |
104 | natural killer cell activation (GO:0030101) | 2.98811134 |
105 | actin-mediated cell contraction (GO:0070252) | 2.98690410 |
106 | positive regulation of cell killing (GO:0031343) | 2.96640368 |
107 | negative regulation of adaptive immune response (GO:0002820) | 2.95007556 |
108 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94826514 |
109 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.94805649 |
110 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.94328193 |
111 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.94042150 |
112 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.93720006 |
113 | T-helper cell differentiation (GO:0042093) | 2.93720006 |
114 | regulation of alpha-beta T cell activation (GO:0046634) | 2.93544477 |
115 | B cell receptor signaling pathway (GO:0050853) | 2.93076075 |
116 | lymphocyte homeostasis (GO:0002260) | 2.91179415 |
117 | growth hormone receptor signaling pathway (GO:0060396) | 2.89753594 |
118 | pigment cell differentiation (GO:0050931) | 2.89697353 |
119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89189408 |
120 | regulation of alkaline phosphatase activity (GO:0010692) | 2.88922667 |
121 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87467957 |
122 | heterotypic cell-cell adhesion (GO:0034113) | 2.86926103 |
123 | positive regulation of B cell proliferation (GO:0030890) | 2.86657064 |
124 | lymph node development (GO:0048535) | 2.84867796 |
125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84053238 |
126 | positive regulation of interleukin-4 production (GO:0032753) | 2.84005406 |
127 | regulation of establishment of cell polarity (GO:2000114) | 2.81986759 |
128 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.78010163 |
129 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.78010163 |
130 | T cell differentiation involved in immune response (GO:0002292) | 2.78010163 |
131 | hypotonic response (GO:0006971) | 2.76802691 |
132 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74707854 |
133 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.64381624 |
134 | positive regulation of natural killer cell activation (GO:0032816) | 2.62932857 |
135 | actin filament-based movement (GO:0030048) | 2.62590711 |
136 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.61379289 |
137 | necroptotic process (GO:0070266) | 2.59108926 |
138 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.56202597 |
139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.55635044 |
140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.55635044 |
141 | pericardium development (GO:0060039) | 2.52549579 |
142 | plasma membrane repair (GO:0001778) | 2.51339517 |
143 | regulation of relaxation of muscle (GO:1901077) | 2.50393590 |
144 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.49679163 |
145 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.48862575 |
146 | response to inactivity (GO:0014854) | 2.48479664 |
147 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.46920480 |
148 | actomyosin structure organization (GO:0031032) | 2.46879046 |
149 | regulation of keratinocyte differentiation (GO:0045616) | 2.46546688 |
150 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.45721991 |
151 | cell-substrate junction assembly (GO:0007044) | 2.45413741 |
152 | cellular response to growth hormone stimulus (GO:0071378) | 2.44725574 |
153 | fibroblast migration (GO:0010761) | 2.44100945 |
154 | regulation of necroptotic process (GO:0060544) | 2.42456106 |
155 | negative regulation of stress fiber assembly (GO:0051497) | 2.42043133 |
156 | negative regulation of monooxygenase activity (GO:0032769) | 2.38268343 |
157 | establishment of protein localization to Golgi (GO:0072600) | 2.36989035 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.91019167 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.34444170 |
3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.46213732 |
4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.36055226 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.88738865 |
6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.77257907 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59885588 |
8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.51372287 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44058531 |
10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40777082 |
11 | MYB_26560356_Chip-Seq_TH2_Human | 3.27774654 |
12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.26935985 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26832856 |
14 | MYC_22102868_ChIP-Seq_BL_Human | 3.17383338 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.07194572 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01731424 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.96391207 |
18 | MYB_26560356_Chip-Seq_TH1_Human | 2.71043583 |
19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.68287088 |
20 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.27044924 |
21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.26031506 |
22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.22038416 |
23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.20240493 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15159632 |
25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14108540 |
26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.11603380 |
27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05884748 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05799028 |
29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05134409 |
30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.04641846 |
31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04538362 |
32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04179793 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02531668 |
34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02269783 |
35 | MAF_26560356_Chip-Seq_TH2_Human | 1.99271914 |
36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97288057 |
37 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.94811644 |
38 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.94811644 |
39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88479790 |
40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.86643089 |
41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85768407 |
42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81348626 |
43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80941581 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.78765985 |
45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78027757 |
46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.70657032 |
47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.68713640 |
48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67382274 |
49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66969119 |
50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64059842 |
51 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.62469698 |
52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62321997 |
53 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.62026282 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62014183 |
55 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60585757 |
56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59373517 |
57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54526626 |
58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54418462 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53950795 |
60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.53124952 |
61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52977106 |
62 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.51331814 |
63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51167647 |
64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44633980 |
65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41951615 |
66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41890354 |
67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41275357 |
68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40338007 |
69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39863037 |
70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39848932 |
71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39786853 |
72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38971075 |
73 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.38165213 |
74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35888205 |
75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32269374 |
76 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29878685 |
77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28978563 |
78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27852532 |
79 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27806977 |
80 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27425371 |
81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27004870 |
82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25817610 |
83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25127405 |
84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24631868 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24631868 |
86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23813327 |
87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23419089 |
88 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23274022 |
89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23219810 |
90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21925645 |
91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20818642 |
92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19763690 |
93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18896605 |
94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16238019 |
95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15804180 |
96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14800295 |
97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12368741 |
98 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10896152 |
99 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10472853 |
100 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09863479 |
101 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08761485 |
102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07728305 |
103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.06564475 |
104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05373025 |
105 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02095910 |
106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01709617 |
107 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01272488 |
108 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01215065 |
109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00040017 |
110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98576022 |
111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98548847 |
112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98484047 |
113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96046145 |
114 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.94198214 |
115 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93964359 |
116 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93806831 |
117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92311015 |
118 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92121654 |
119 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92011423 |
120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91974757 |
121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91895361 |
122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.91837285 |
123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91736950 |
124 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90689146 |
125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90294455 |
126 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90180769 |
127 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89608303 |
128 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.88674616 |
129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88218117 |
130 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87437025 |
131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87075889 |
132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86516758 |
133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85684439 |
134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84133410 |
135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82419144 |
136 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82104859 |
137 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81001049 |
138 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79710359 |
139 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79472154 |
140 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79062315 |
141 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78728944 |
142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76528711 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74618819 |
144 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74542697 |
145 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74065515 |
146 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73407295 |
147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73020533 |
148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72946531 |
149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71966326 |
150 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71285995 |
151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69204329 |
152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67941243 |
153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65986048 |
154 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65946519 |
155 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64304899 |
156 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62891849 |
157 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.62072371 |
158 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61947211 |
159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.59983572 |
160 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.56803591 |
161 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.55720517 |
162 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.55720517 |
163 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55454174 |
164 | GATA3_26560356_Chip-Seq_TH1_Human | 0.55071310 |
165 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53629332 |
166 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.53021639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.79760959 |
2 | MP0005671_abnormal_response_to | 4.64959348 |
3 | MP0000372_irregular_coat_pigmentation | 3.99597499 |
4 | MP0000569_abnormal_digit_pigmentation | 3.79570100 |
5 | MP0003950_abnormal_plasma_membrane | 3.43661377 |
6 | MP0003300_gastrointestinal_ulcer | 3.33769656 |
7 | MP0000685_abnormal_immune_system | 3.27149510 |
8 | MP0005171_absent_coat_pigmentation | 3.23465229 |
9 | MP0002166_altered_tumor_susceptibility | 3.20546431 |
10 | MP0001800_abnormal_humoral_immune | 3.10238314 |
11 | MP0000015_abnormal_ear_pigmentation | 3.09097797 |
12 | MP0005408_hypopigmentation | 3.08819281 |
13 | MP0001835_abnormal_antigen_presentation | 3.06413724 |
14 | MP0005387_immune_system_phenotype | 3.00188673 |
15 | MP0001790_abnormal_immune_system | 3.00188673 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.91327896 |
17 | MP0005000_abnormal_immune_tolerance | 2.87231477 |
18 | MP0002420_abnormal_adaptive_immunity | 2.69988898 |
19 | MP0002398_abnormal_bone_marrow | 2.67782051 |
20 | MP0001819_abnormal_immune_cell | 2.65665220 |
21 | MP0002723_abnormal_immune_serum | 2.65591367 |
22 | MP0001873_stomach_inflammation | 2.61298353 |
23 | MP0003436_decreased_susceptibility_to | 2.56126253 |
24 | MP0000703_abnormal_thymus_morphology | 2.52878548 |
25 | MP0002405_respiratory_system_inflammati | 2.50435138 |
26 | MP0002006_tumorigenesis | 2.49119628 |
27 | MP0003866_abnormal_defecation | 2.48553748 |
28 | MP0002452_abnormal_antigen_presenting | 2.44650665 |
29 | MP0000749_muscle_degeneration | 2.36137973 |
30 | MP0000716_abnormal_immune_system | 2.30460162 |
31 | MP0006082_CNS_inflammation | 2.26829052 |
32 | MP0002396_abnormal_hematopoietic_system | 2.24575536 |
33 | MP0002722_abnormal_immune_system | 2.18839580 |
34 | MP0010155_abnormal_intestine_physiology | 2.18542775 |
35 | MP0009785_altered_susceptibility_to | 2.18395516 |
36 | MP0004510_myositis | 2.17188080 |
37 | MP0005025_abnormal_response_to | 2.14206927 |
38 | MP0003724_increased_susceptibility_to | 2.11618798 |
39 | MP0000689_abnormal_spleen_morphology | 2.07884957 |
40 | MP0005174_abnormal_tail_pigmentation | 2.07749083 |
41 | MP0000465_gastrointestinal_hemorrhage | 2.02507427 |
42 | MP0003303_peritoneal_inflammation | 2.00312999 |
43 | MP0002009_preneoplasia | 2.00278610 |
44 | MP0010234_abnormal_vibrissa_follicle | 2.00254124 |
45 | MP0004947_skin_inflammation | 1.98972474 |
46 | MP0002933_joint_inflammation | 1.92980673 |
47 | MP0000371_diluted_coat_color | 1.85298532 |
48 | MP0002429_abnormal_blood_cell | 1.84844808 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.84127365 |
50 | MP0002148_abnormal_hypersensitivity_rea | 1.81999907 |
51 | MP0001853_heart_inflammation | 1.74953587 |
52 | MP0000427_abnormal_hair_cycle | 1.70574427 |
53 | MP0004808_abnormal_hematopoietic_stem | 1.66177032 |
54 | MP0002095_abnormal_skin_pigmentation | 1.63200968 |
55 | MP0005464_abnormal_platelet_physiology | 1.63107804 |
56 | MP0002419_abnormal_innate_immunity | 1.63033375 |
57 | MP0001845_abnormal_inflammatory_respons | 1.57034784 |
58 | MP0006054_spinal_hemorrhage | 1.50727511 |
59 | MP0004381_abnormal_hair_follicle | 1.49661930 |
60 | MP0003045_fibrosis | 1.42565009 |
61 | MP0004484_altered_response_of | 1.40526444 |
62 | MP0010678_abnormal_skin_adnexa | 1.38715592 |
63 | MP0002060_abnormal_skin_morphology | 1.31941697 |
64 | MP0008961_abnormal_basal_metabolism | 1.31705824 |
65 | MP0001851_eye_inflammation | 1.29829305 |
66 | MP0004883_abnormal_blood_vessel | 1.27175681 |
67 | MP0005310_abnormal_salivary_gland | 1.24500819 |
68 | MP0003191_abnormal_cellular_cholesterol | 1.22577239 |
69 | MP0005275_abnormal_skin_tensile | 1.22368323 |
70 | MP0005409_darkened_coat_color | 1.21897953 |
71 | MP0003448_altered_tumor_morphology | 1.19201856 |
72 | MP0001348_abnormal_lacrimal_gland | 1.18331426 |
73 | MP0001533_abnormal_skeleton_physiology | 1.17490368 |
74 | MP0000858_altered_metastatic_potential | 1.10310698 |
75 | MP0002332_abnormal_exercise_endurance | 1.08535092 |
76 | MP0004233_abnormal_muscle_weight | 1.01744934 |
77 | MP0005164_abnormal_response_to | 1.00751462 |
78 | MP0000759_abnormal_skeletal_muscle | 1.00655505 |
79 | MP0000751_myopathy | 0.99800280 |
80 | MP0002075_abnormal_coat/hair_pigmentati | 0.97964019 |
81 | MP0008469_abnormal_protein_level | 0.94520235 |
82 | MP0005023_abnormal_wound_healing | 0.93755912 |
83 | MP0004264_abnormal_extraembryonic_tissu | 0.93617701 |
84 | MP0004087_abnormal_muscle_fiber | 0.92931520 |
85 | MP0002998_abnormal_bone_remodeling | 0.92898208 |
86 | MP0002269_muscular_atrophy | 0.92410714 |
87 | MP0005620_abnormal_muscle_contractility | 0.92229121 |
88 | MP0004084_abnormal_cardiac_muscle | 0.90441555 |
89 | MP0005075_abnormal_melanosome_morpholog | 0.89183724 |
90 | MP0001186_pigmentation_phenotype | 0.87822656 |
91 | MP0000377_abnormal_hair_follicle | 0.86448331 |
92 | MP0000490_abnormal_crypts_of | 0.85558417 |
93 | MP0001958_emphysema | 0.85410035 |
94 | MP0008438_abnormal_cutaneous_collagen | 0.84023690 |
95 | MP0002796_impaired_skin_barrier | 0.80467396 |
96 | MP0001542_abnormal_bone_strength | 0.80301935 |
97 | MP0000750_abnormal_muscle_regeneration | 0.79823109 |
98 | MP0001661_extended_life_span | 0.78678150 |
99 | MP0003646_muscle_fatigue | 0.78360616 |
100 | MP0002019_abnormal_tumor_incidence | 0.78200788 |
101 | MP0000013_abnormal_adipose_tissue | 0.78064623 |
102 | MP0005397_hematopoietic_system_phenotyp | 0.76632343 |
103 | MP0001545_abnormal_hematopoietic_system | 0.76632343 |
104 | MP0004134_abnormal_chest_morphology | 0.76607817 |
105 | MP0000627_abnormal_mammary_gland | 0.76228988 |
106 | MP0003136_yellow_coat_color | 0.76216312 |
107 | MP0001243_abnormal_dermal_layer | 0.75900838 |
108 | MP0002108_abnormal_muscle_morphology | 0.75433465 |
109 | MP0005076_abnormal_cell_differentiation | 0.73838675 |
110 | MP0010352_gastrointestinal_tract_polyps | 0.72221682 |
111 | MP0008569_lethality_at_weaning | 0.71776020 |
112 | MP0002972_abnormal_cardiac_muscle | 0.71533933 |
113 | MP0003172_abnormal_lysosome_physiology | 0.68848458 |
114 | MP0003787_abnormal_imprinting | 0.65996177 |
115 | MP0003828_pulmonary_edema | 0.64329230 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.63819904 |
117 | MP0003795_abnormal_bone_structure | 0.62203781 |
118 | MP0003279_aneurysm | 0.60372676 |
119 | MP0009764_decreased_sensitivity_to | 0.59154326 |
120 | MP0000604_amyloidosis | 0.58564722 |
121 | MP0009763_increased_sensitivity_to | 0.58139530 |
122 | MP0000249_abnormal_blood_vessel | 0.57397898 |
123 | MP0003453_abnormal_keratinocyte_physiol | 0.56357125 |
124 | MP0003091_abnormal_cell_migration | 0.54815416 |
125 | MP0000733_abnormal_muscle_development | 0.52536510 |
126 | MP0003566_abnormal_cell_adhesion | 0.52526184 |
127 | MP0004185_abnormal_adipocyte_glucose | 0.52521525 |
128 | MP0001881_abnormal_mammary_gland | 0.51165258 |
129 | MP0001663_abnormal_digestive_system | 0.51036336 |
130 | MP0008775_abnormal_heart_ventricle | 0.50365834 |
131 | MP0002877_abnormal_melanocyte_morpholog | 0.48402096 |
132 | MP0008007_abnormal_cellular_replicative | 0.47366353 |
133 | MP0008057_abnormal_DNA_replication | 0.46918280 |
134 | MP0002822_catalepsy | 0.46668660 |
135 | MP0009384_cardiac_valve_regurgitation | 0.46533846 |
136 | MP0000343_altered_response_to | 0.46530766 |
137 | MP0000477_abnormal_intestine_morphology | 0.44802316 |
138 | MP0010630_abnormal_cardiac_muscle | 0.44286850 |
139 | MP0004130_abnormal_muscle_cell | 0.39983366 |
140 | MP0001216_abnormal_epidermal_layer | 0.39912346 |
141 | MP0001191_abnormal_skin_condition | 0.39850045 |
142 | MP0003183_abnormal_peptide_metabolism | 0.39554523 |
143 | MP0005390_skeleton_phenotype | 0.39348062 |
144 | MP0005165_increased_susceptibility_to | 0.38453506 |
145 | MP0002693_abnormal_pancreas_physiology | 0.38303547 |
146 | MP0000383_abnormal_hair_follicle | 0.37379843 |
147 | MP0000367_abnormal_coat/_hair | 0.34834911 |
148 | MP0004036_abnormal_muscle_relaxation | 0.34119140 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 7.36587035 |
2 | Abnormality of T cell number (HP:0011839) | 7.03020533 |
3 | Stomatitis (HP:0010280) | 5.27342080 |
4 | Recurrent bronchitis (HP:0002837) | 5.26462735 |
5 | Abnormality of T cells (HP:0002843) | 5.24011262 |
6 | Popliteal pterygium (HP:0009756) | 4.79206916 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.76053175 |
8 | IgM deficiency (HP:0002850) | 4.74030368 |
9 | Severe combined immunodeficiency (HP:0004430) | 4.72033639 |
10 | Recurrent fungal infections (HP:0002841) | 4.43656352 |
11 | Chronic diarrhea (HP:0002028) | 4.39366969 |
12 | Chronic otitis media (HP:0000389) | 4.29559883 |
13 | Combined immunodeficiency (HP:0005387) | 4.22486723 |
14 | Recurrent viral infections (HP:0004429) | 4.17267510 |
15 | Nemaline bodies (HP:0003798) | 4.12712815 |
16 | Myositis (HP:0100614) | 4.02884111 |
17 | IgG deficiency (HP:0004315) | 4.02355600 |
18 | Abnormality of the fingertips (HP:0001211) | 3.96125524 |
19 | Nasal polyposis (HP:0100582) | 3.88930141 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.88442575 |
21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.88442575 |
22 | Panhypogammaglobulinemia (HP:0003139) | 3.81769466 |
23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.80038991 |
24 | Abnormality of the neuromuscular junction (HP:0003398) | 3.71895638 |
25 | Fatigable weakness (HP:0003473) | 3.71895638 |
26 | IgA deficiency (HP:0002720) | 3.65409507 |
27 | Type 2 muscle fiber atrophy (HP:0003554) | 3.64725508 |
28 | Autoimmune hemolytic anemia (HP:0001890) | 3.64004125 |
29 | Hyporeflexia of lower limbs (HP:0002600) | 3.62663481 |
30 | Muscle fiber inclusion bodies (HP:0100299) | 3.56531413 |
31 | Milia (HP:0001056) | 3.54573967 |
32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53477779 |
33 | B lymphocytopenia (HP:0010976) | 3.51076242 |
34 | Abnormality of B cell number (HP:0010975) | 3.51076242 |
35 | Abnormality of eosinophils (HP:0001879) | 3.50885377 |
36 | Pustule (HP:0200039) | 3.42249929 |
37 | Abnormality of T cell physiology (HP:0011840) | 3.41666944 |
38 | Abnormality of placental membranes (HP:0011409) | 3.41300263 |
39 | Amniotic constriction ring (HP:0009775) | 3.41300263 |
40 | Eczematoid dermatitis (HP:0000976) | 3.41103726 |
41 | Lymphopenia (HP:0001888) | 3.36472560 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 3.30740534 |
43 | Retrobulbar optic neuritis (HP:0100654) | 3.30422098 |
44 | Optic neuritis (HP:0100653) | 3.30422098 |
45 | Ocular albinism (HP:0001107) | 3.26853209 |
46 | Subaortic stenosis (HP:0001682) | 3.24229580 |
47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.24229580 |
48 | Glucose intolerance (HP:0000833) | 3.21307237 |
49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.18957661 |
50 | Joint swelling (HP:0001386) | 3.18018833 |
51 | Weak cry (HP:0001612) | 3.17446782 |
52 | Inflammation of the large intestine (HP:0002037) | 3.09200754 |
53 | Eosinophilia (HP:0001880) | 3.06564044 |
54 | Muscle fiber atrophy (HP:0100295) | 3.05650204 |
55 | Increased IgM level (HP:0003496) | 3.01803677 |
56 | Leukocytosis (HP:0001974) | 2.99980184 |
57 | Blue irides (HP:0000635) | 2.99728700 |
58 | Hemoptysis (HP:0002105) | 2.97020645 |
59 | Gastrointestinal inflammation (HP:0004386) | 2.95757911 |
60 | Vasculitis (HP:0002633) | 2.95483291 |
61 | Calf muscle hypertrophy (HP:0008981) | 2.93716787 |
62 | Thyroiditis (HP:0100646) | 2.93613645 |
63 | Absent frontal sinuses (HP:0002688) | 2.91579426 |
64 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.90634246 |
65 | Bronchitis (HP:0012387) | 2.89874848 |
66 | Increased density of long bones (HP:0006392) | 2.86817779 |
67 | Pulmonary infiltrates (HP:0002113) | 2.84510094 |
68 | Orchitis (HP:0100796) | 2.78453175 |
69 | Sudden death (HP:0001699) | 2.78043728 |
70 | Aortic dissection (HP:0002647) | 2.77203724 |
71 | Neck muscle weakness (HP:0000467) | 2.74519553 |
72 | Recurrent sinusitis (HP:0011108) | 2.73356048 |
73 | Malignant hyperthermia (HP:0002047) | 2.69430076 |
74 | Atrophic scars (HP:0001075) | 2.68991719 |
75 | Distal lower limb muscle weakness (HP:0009053) | 2.67866392 |
76 | Arterial thrombosis (HP:0004420) | 2.66192570 |
77 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.65837996 |
78 | Hypoplasia of the fovea (HP:0007750) | 2.60183449 |
79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.60183449 |
80 | Granulocytopenia (HP:0001913) | 2.59677517 |
81 | Aplasia of the musculature (HP:0100854) | 2.57888115 |
82 | Generalized hypopigmentation of hair (HP:0011358) | 2.56836929 |
83 | Albinism (HP:0001022) | 2.56534431 |
84 | Chest pain (HP:0100749) | 2.56449280 |
85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.55679872 |
86 | Osteolytic defects of the hand bones (HP:0009699) | 2.55679872 |
87 | Onycholysis (HP:0001806) | 2.55442086 |
88 | Gastrointestinal infarctions (HP:0005244) | 2.54765811 |
89 | Iris hypopigmentation (HP:0007730) | 2.54757739 |
90 | Cutaneous melanoma (HP:0012056) | 2.54480189 |
91 | Gowers sign (HP:0003391) | 2.53987598 |
92 | Abnormal platelet volume (HP:0011876) | 2.53144460 |
93 | Spontaneous hematomas (HP:0007420) | 2.51816039 |
94 | Meningitis (HP:0001287) | 2.51519036 |
95 | Basal cell carcinoma (HP:0002671) | 2.49120391 |
96 | Mediastinal lymphadenopathy (HP:0100721) | 2.44718681 |
97 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.44586921 |
98 | Asymmetric septal hypertrophy (HP:0001670) | 2.43331959 |
99 | White forelock (HP:0002211) | 2.42083143 |
100 | Bundle branch block (HP:0011710) | 2.40590987 |
101 | Aortic aneurysm (HP:0004942) | 2.40068422 |
102 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.39167162 |
103 | Metaphyseal dysplasia (HP:0100255) | 2.38722018 |
104 | Lymphoma (HP:0002665) | 2.38687339 |
105 | Plantar hyperkeratosis (HP:0007556) | 2.37842442 |
106 | Abnormal auditory evoked potentials (HP:0006958) | 2.37660714 |
107 | Increased IgE level (HP:0003212) | 2.36959725 |
108 | Thrombocytosis (HP:0001894) | 2.34540780 |
109 | Gastrointestinal stroma tumor (HP:0100723) | 2.32785887 |
110 | Encephalitis (HP:0002383) | 2.32453865 |
111 | Spondylolisthesis (HP:0003302) | 2.32422036 |
112 | Easy fatigability (HP:0003388) | 2.32413126 |
113 | Prolonged bleeding time (HP:0003010) | 2.32281759 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 2.31802125 |
115 | Chronic sinusitis (HP:0011109) | 2.31648990 |
116 | Papilloma (HP:0012740) | 2.30109555 |
117 | Verrucae (HP:0200043) | 2.30109555 |
118 | Ureteral stenosis (HP:0000071) | 2.28290466 |
119 | Arterial tortuosity (HP:0005116) | 2.27679398 |
120 | Abnormal glucose tolerance (HP:0001952) | 2.27451608 |
121 | Patchy hypopigmentation of hair (HP:0011365) | 2.26516849 |
122 | Hypergammaglobulinemia (HP:0010702) | 2.25038084 |
123 | Round ear (HP:0100830) | 2.24576929 |
124 | Agammaglobulinemia (HP:0004432) | 2.23433369 |
125 | Lip pit (HP:0100267) | 2.22647741 |
126 | Fatigue (HP:0012378) | 2.22287095 |
127 | Abnormality of the calf musculature (HP:0001430) | 2.22276443 |
128 | Generalized hypopigmentation (HP:0007513) | 2.19509760 |
129 | Cheilitis (HP:0100825) | 2.18806765 |
130 | Hypoplasia of the iris (HP:0007676) | 2.17777879 |
131 | Dislocated radial head (HP:0003083) | 2.17646635 |
132 | Abnormality of the fovea (HP:0000493) | 2.16575852 |
133 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16449294 |
134 | Hypoplasia of the thymus (HP:0000778) | 2.16179437 |
135 | Increased mean platelet volume (HP:0011877) | 2.15563244 |
136 | Trigonocephaly (HP:0000243) | 2.14648026 |
137 | Hypopigmentation of the fundus (HP:0007894) | 2.14046957 |
138 | Periodontitis (HP:0000704) | 2.14023980 |
139 | Gingival bleeding (HP:0000225) | 2.13638139 |
140 | Emphysema (HP:0002097) | 2.12801297 |
141 | Abnormality of the radial head (HP:0003995) | 2.12694984 |
142 | Fetal akinesia sequence (HP:0001989) | 2.12387362 |
143 | Exercise-induced myalgia (HP:0003738) | 2.11855370 |
144 | Subacute progressive viral hepatitis (HP:0006572) | 2.11738542 |
145 | Recurrent skin infections (HP:0001581) | 2.11527206 |
146 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11477881 |
147 | Obstructive lung disease (HP:0006536) | 2.11477881 |
148 | Ureteral obstruction (HP:0006000) | 2.09321342 |
149 | Epistaxis (HP:0000421) | 2.08350687 |
150 | Vascular tortuosity (HP:0004948) | 2.08284551 |
151 | Recurrent abscess formation (HP:0002722) | 2.06941355 |
152 | Persistence of primary teeth (HP:0006335) | 2.06460790 |
153 | Keratoconjunctivitis (HP:0001096) | 2.04894476 |
154 | Pulmonary embolism (HP:0002204) | 2.04595402 |
155 | Recurrent otitis media (HP:0000403) | 2.04542999 |
156 | Colitis (HP:0002583) | 2.04361528 |
157 | Micronodular cirrhosis (HP:0001413) | 2.03776946 |
158 | Abnormality of the frontal sinuses (HP:0002687) | 2.03588089 |
159 | Autoimmune thrombocytopenia (HP:0001973) | 2.03152827 |
160 | Pterygium (HP:0001059) | 2.02969739 |
161 | Cystic hygroma (HP:0000476) | 2.02632084 |
162 | Bicuspid aortic valve (HP:0001647) | 2.02510594 |
163 | Ulnar deviation of the wrist (HP:0003049) | 2.01406400 |
164 | Abnormality of binocular vision (HP:0011514) | 2.00816044 |
165 | Diplopia (HP:0000651) | 2.00816044 |
166 | Alopecia of scalp (HP:0002293) | 1.97414409 |
167 | Abnormality of oral frenula (HP:0000190) | 1.96382296 |
168 | Right ventricular cardiomyopathy (HP:0011663) | 1.95695019 |
169 | Frequent falls (HP:0002359) | 1.93772805 |
170 | Type 1 muscle fiber predominance (HP:0003803) | 1.93284467 |
171 | Thick nail (HP:0001805) | 1.92926454 |
172 | Papilledema (HP:0001085) | 1.91582696 |
173 | Abnormality of the prostate (HP:0008775) | 1.90085660 |
174 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.89261810 |
175 | Anhidrosis (HP:0000970) | 1.88893151 |
176 | Areflexia of lower limbs (HP:0002522) | 1.88565836 |
177 | Dysmetric saccades (HP:0000641) | 1.87811224 |
178 | Premature graying of hair (HP:0002216) | 1.87408773 |
179 | Cerebral aneurysm (HP:0004944) | 1.86156046 |
180 | Lipoatrophy (HP:0100578) | 1.84311253 |
181 | Nail dystrophy (HP:0008404) | 1.82590486 |
182 | Distal arthrogryposis (HP:0005684) | 1.76462020 |
183 | Palmoplantar hyperkeratosis (HP:0000972) | 1.75883956 |
184 | Akinesia (HP:0002304) | 1.73910359 |
185 | Ventricular tachycardia (HP:0004756) | 1.72501360 |
186 | EMG: myopathic abnormalities (HP:0003458) | 1.72384184 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.37582371 |
2 | MAP4K1 | 5.55127609 |
3 | MUSK | 3.79433861 |
4 | FGFR4 | 3.78155763 |
5 | ITK | 3.66544224 |
6 | FRK | 3.34435258 |
7 | JAK3 | 3.25986408 |
8 | ZAP70 | 3.04405630 |
9 | SCYL2 | 2.88186262 |
10 | TAOK3 | 2.79245614 |
11 | MAP3K12 | 2.71012430 |
12 | FGFR3 | 2.65189661 |
13 | TYK2 | 2.65100025 |
14 | STK10 | 2.54713970 |
15 | MST1R | 2.44577122 |
16 | IKBKE | 2.39200616 |
17 | PIK3CA | 2.27431549 |
18 | JAK1 | 2.26714906 |
19 | MYLK | 2.24390222 |
20 | OBSCN | 2.12111430 |
21 | PIK3CG | 2.11618507 |
22 | LCK | 1.90902733 |
23 | NLK | 1.84277648 |
24 | TEC | 1.81077882 |
25 | EEF2K | 1.69951996 |
26 | MAP3K14 | 1.68169883 |
27 | GRK6 | 1.61673439 |
28 | TGFBR2 | 1.56912313 |
29 | HCK | 1.51588890 |
30 | NEK6 | 1.51311110 |
31 | BMPR2 | 1.49329248 |
32 | PRKCQ | 1.43885559 |
33 | CSK | 1.42747534 |
34 | MAP3K13 | 1.38309300 |
35 | FGFR2 | 1.35426695 |
36 | EIF2AK3 | 1.34593575 |
37 | MAPKAPK3 | 1.32385489 |
38 | KIT | 1.30936187 |
39 | CAMKK2 | 1.30705092 |
40 | SYK | 1.30256540 |
41 | LATS1 | 1.29270624 |
42 | STK38 | 1.27733961 |
43 | EPHA2 | 1.26641606 |
44 | TBK1 | 1.26354368 |
45 | ERBB3 | 1.26111461 |
46 | MET | 1.25662640 |
47 | PRKCH | 1.25529581 |
48 | MAP3K3 | 1.23143873 |
49 | BTK | 1.21569629 |
50 | MARK3 | 1.19612742 |
51 | MAP3K7 | 1.19187506 |
52 | PKN2 | 1.18064253 |
53 | EPHA3 | 1.17712137 |
54 | TTN | 1.17319868 |
55 | PTK2B | 1.16159765 |
56 | AKT3 | 1.14802487 |
57 | STK39 | 1.05240436 |
58 | RPS6KB2 | 1.03214380 |
59 | FER | 1.03089061 |
60 | JAK2 | 1.01975140 |
61 | KDR | 0.97219412 |
62 | TYRO3 | 0.96005145 |
63 | LRRK2 | 0.95558292 |
64 | CDK12 | 0.92961976 |
65 | MAP3K2 | 0.92938932 |
66 | IKBKB | 0.92563647 |
67 | DMPK | 0.89545761 |
68 | SIK2 | 0.87143637 |
69 | MAP3K10 | 0.86819749 |
70 | IRAK4 | 0.86768570 |
71 | PDGFRB | 0.84943355 |
72 | PAK3 | 0.83377295 |
73 | MAP2K1 | 0.81027614 |
74 | CHUK | 0.80741577 |
75 | MST4 | 0.78486232 |
76 | CLK1 | 0.77915723 |
77 | FGFR1 | 0.76739592 |
78 | TRIM28 | 0.74795583 |
79 | NME2 | 0.73655829 |
80 | FES | 0.73129845 |
81 | TRIB3 | 0.70442331 |
82 | CDK8 | 0.70307909 |
83 | EIF2AK2 | 0.69409414 |
84 | EIF2AK1 | 0.69319668 |
85 | HIPK2 | 0.68501455 |
86 | PIM1 | 0.65853253 |
87 | MAP2K2 | 0.65779858 |
88 | TNK2 | 0.65545603 |
89 | LYN | 0.64348450 |
90 | EPHB1 | 0.63800697 |
91 | NTRK2 | 0.61883675 |
92 | ACVR1B | 0.60913858 |
93 | MARK2 | 0.60775285 |
94 | CDK6 | 0.60491944 |
95 | BLK | 0.59972545 |
96 | PDK1 | 0.59170260 |
97 | RPS6KA4 | 0.57871275 |
98 | LIMK1 | 0.57649511 |
99 | IRAK1 | 0.56386903 |
100 | MAPK7 | 0.54923181 |
101 | TGFBR1 | 0.53591785 |
102 | MELK | 0.52652700 |
103 | FLT3 | 0.50464045 |
104 | ILK | 0.49361717 |
105 | PRKD2 | 0.48249847 |
106 | BMPR1B | 0.48074895 |
107 | IGF1R | 0.47884656 |
108 | TAOK1 | 0.47831497 |
109 | RIPK1 | 0.47346433 |
110 | SIK3 | 0.46672094 |
111 | PDGFRA | 0.46208158 |
112 | ADRBK1 | 0.45113948 |
113 | PTK2 | 0.44679790 |
114 | STK3 | 0.43693766 |
115 | CSF1R | 0.43134453 |
116 | INSR | 0.42797795 |
117 | CDK9 | 0.42392042 |
118 | MAP2K3 | 0.41777836 |
119 | PAK4 | 0.41485156 |
120 | CDK4 | 0.39855400 |
121 | NUAK1 | 0.39755615 |
122 | FYN | 0.39200891 |
123 | MAPK12 | 0.38031421 |
124 | BRD4 | 0.37618555 |
125 | MAPK11 | 0.36476236 |
126 | SGK3 | 0.35547296 |
127 | RET | 0.35244054 |
128 | STK4 | 0.34361934 |
129 | ALK | 0.33440174 |
130 | PTK6 | 0.33123174 |
131 | NEK9 | 0.32403578 |
132 | STK24 | 0.30317361 |
133 | EGFR | 0.29440524 |
134 | CAMK1G | 0.29082966 |
135 | IRAK2 | 0.28482234 |
136 | PRKD1 | 0.28320700 |
137 | RPS6KA5 | 0.27299631 |
138 | TSSK6 | 0.26128304 |
139 | MAPKAPK2 | 0.25899646 |
140 | CAMK1D | 0.25823561 |
141 | TRPM7 | 0.24771021 |
142 | MAPK3 | 0.23840258 |
143 | ROCK2 | 0.22610914 |
144 | SIK1 | 0.19163234 |
145 | ABL1 | 0.17390762 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.04944624 |
2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.97889693 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.31897964 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 3.00263784 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.79725753 |
6 | Measles_Homo sapiens_hsa05162 | 2.58169253 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51003670 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43549850 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30638972 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.21955496 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21676505 |
12 | Asthma_Homo sapiens_hsa05310 | 2.01824432 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96329344 |
14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.94925510 |
15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90087393 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78151238 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74612320 |
18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.69695239 |
19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68549122 |
20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51536518 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49250224 |
22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.39432141 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37402078 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34686221 |
25 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30872141 |
26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29238865 |
27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28412209 |
28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28286243 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28066100 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27232255 |
31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25486996 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.22852492 |
33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22464150 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17813811 |
35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15132414 |
36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12881520 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.12636223 |
38 | HTLV-I infection_Homo sapiens_hsa05166 | 1.12394050 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06861259 |
40 | Glioma_Homo sapiens_hsa05214 | 1.02129382 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00339209 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97000988 |
43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96290115 |
44 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95154513 |
45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93820585 |
46 | Influenza A_Homo sapiens_hsa05164 | 0.92646903 |
47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90491804 |
48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.89985170 |
49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87029543 |
50 | Apoptosis_Homo sapiens_hsa04210 | 0.84956215 |
51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82950500 |
52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82534111 |
53 | Shigellosis_Homo sapiens_hsa05131 | 0.81792963 |
54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81653346 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81189140 |
56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79848830 |
57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79374801 |
58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78950039 |
59 | Melanoma_Homo sapiens_hsa05218 | 0.77823531 |
60 | Malaria_Homo sapiens_hsa05144 | 0.76932879 |
61 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72465829 |
62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72294286 |
63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72030602 |
64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71209920 |
65 | ABC transporters_Homo sapiens_hsa02010 | 0.71036122 |
66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68605206 |
67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68497435 |
68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68016804 |
69 | Hepatitis C_Homo sapiens_hsa05160 | 0.67669088 |
70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67529232 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66054405 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65591692 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.65572429 |
74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65427055 |
75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64539080 |
76 | Tuberculosis_Homo sapiens_hsa05152 | 0.64456673 |
77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64296850 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64138632 |
79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63678575 |
80 | Tight junction_Homo sapiens_hsa04530 | 0.63444608 |
81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63083200 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62868796 |
83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62069841 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60899317 |
85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60344889 |
86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60026959 |
87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59716273 |
88 | Renin secretion_Homo sapiens_hsa04924 | 0.59490589 |
89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59213833 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.57139356 |
91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55570577 |
92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52893554 |
93 | Salivary secretion_Homo sapiens_hsa04970 | 0.52593946 |
94 | Salmonella infection_Homo sapiens_hsa05132 | 0.51759429 |
95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49867556 |
96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48396288 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.47770286 |
98 | Adherens junction_Homo sapiens_hsa04520 | 0.47640558 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47587113 |
100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46130598 |
101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44788512 |
102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44150077 |
103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43742164 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42949420 |
105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42928202 |
106 | Legionellosis_Homo sapiens_hsa05134 | 0.42486761 |
107 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41544683 |
108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41413352 |
109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41290408 |
110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40861437 |
111 | Focal adhesion_Homo sapiens_hsa04510 | 0.38572525 |
112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37967725 |
113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36836610 |
114 | Prostate cancer_Homo sapiens_hsa05215 | 0.36797604 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36718240 |
116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36284852 |
117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35951882 |
118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35592684 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34892702 |
120 | Pertussis_Homo sapiens_hsa05133 | 0.32983943 |
121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30713581 |
122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30097164 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27085318 |